Association of baseline advanced HIV disease and dolutegravir versus non-dolutegravir regimen status with viral load suppression among patients on antiretroviral therapy in Tanzania
In a retrospective cohort study of Tanzanian patients on antiretroviral therapy, dolutegravir-based regimens were associated with improved viral load suppression overall, with a particularly significant relative benefit observed among patients presenting with baseline advanced HIV disease.